Louisiana State Employees Retirement System increased its stake in shares of Luminex Corporation (NASDAQ:LMNX) by 7.2% during the second quarter, Holdings Channel reports. The firm owned 16,300 shares of the medical instruments supplier’s stock after buying an additional 1,100 shares during the period. Louisiana State Employees Retirement System’s holdings in Luminex Corporation were worth $344,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the stock. Sei Investments Co. raised its position in Luminex Corporation by 10.9% in the first quarter. Sei Investments Co. now owns 5,946 shares of the medical instruments supplier’s stock valued at $110,000 after buying an additional 582 shares during the period. BNP Paribas Arbitrage SA raised its position in Luminex Corporation by 6.7% in the first quarter. BNP Paribas Arbitrage SA now owns 7,780 shares of the medical instruments supplier’s stock valued at $143,000 after buying an additional 489 shares during the period. Mason Street Advisors LLC raised its position in Luminex Corporation by 0.5% in the first quarter. Mason Street Advisors LLC now owns 8,713 shares of the medical instruments supplier’s stock valued at $160,000 after buying an additional 46 shares during the period. State of Alaska Department of Revenue raised its position in Luminex Corporation by 92.1% in the second quarter. State of Alaska Department of Revenue now owns 7,895 shares of the medical instruments supplier’s stock valued at $166,000 after buying an additional 3,785 shares during the period. Finally, Creative Planning raised its position in Luminex Corporation by 5.4% in the first quarter. Creative Planning now owns 9,256 shares of the medical instruments supplier’s stock valued at $170,000 after buying an additional 474 shares during the period. Institutional investors own 73.36% of the company’s stock.

Shares of Luminex Corporation (NASDAQ:LMNX) traded up 0.10% during midday trading on Wednesday, hitting $19.32. The stock had a trading volume of 32,552 shares. The stock has a market cap of $851.45 million, a PE ratio of 59.81 and a beta of 0.29. The firm has a 50 day moving average price of $20.49 and a 200 day moving average price of $19.63. Luminex Corporation has a one year low of $17.64 and a one year high of $23.62.

Luminex Corporation (NASDAQ:LMNX) last released its quarterly earnings data on Monday, August 7th. The medical instruments supplier reported $0.20 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.11. Luminex Corporation had a return on equity of 4.81% and a net margin of 4.72%. The business had revenue of $76.50 million for the quarter, compared to the consensus estimate of $75.45 million. During the same quarter in the prior year, the business posted $0.33 EPS. The business’s revenue for the quarter was up 19.2% on a year-over-year basis. On average, equities analysts forecast that Luminex Corporation will post $0.54 earnings per share for the current fiscal year.

WARNING: “Louisiana State Employees Retirement System Has $344,000 Position in Luminex Corporation (LMNX)” was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this news story on another website, it was stolen and republished in violation of US & international copyright & trademark laws. The correct version of this news story can be accessed at https://www.dailypolitical.com/2017/08/16/louisiana-state-employees-retirement-system-has-344000-position-in-luminex-corporation-lmnx.html.

Several equities analysts have issued reports on LMNX shares. TheStreet upgraded Luminex Corporation from a “c+” rating to a “b-” rating in a research note on Friday, May 19th. Zacks Investment Research upgraded Luminex Corporation from a “hold” rating to a “buy” rating and set a $23.00 target price on the stock in a research note on Monday, July 17th. Jefferies Group LLC lifted their target price on Luminex Corporation from $20.00 to $21.00 and gave the company a “hold” rating in a research note on Tuesday, May 2nd. ValuEngine upgraded Luminex Corporation from a “sell” rating to a “hold” rating in a research note on Thursday, May 11th. Finally, BidaskClub lowered Luminex Corporation from a “hold” rating to a “sell” rating in a research note on Friday, July 28th. Three equities research analysts have rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the company. Luminex Corporation currently has a consensus rating of “Hold” and an average price target of $21.67.

In other news, Director G Walter Loewenbaum II sold 25,000 shares of the stock in a transaction dated Tuesday, May 23rd. The stock was sold at an average price of $20.23, for a total value of $505,750.00. Following the transaction, the director now owns 738,896 shares in the company, valued at approximately $14,947,866.08. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In the last quarter, insiders sold 75,000 shares of company stock worth $1,527,500. Company insiders own 6.90% of the company’s stock.

Luminex Corporation Company Profile

Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company’s products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments.

Want to see what other hedge funds are holding LMNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Luminex Corporation (NASDAQ:LMNX).

Institutional Ownership by Quarter for Luminex Corporation (NASDAQ:LMNX)

Receive News & Ratings for Luminex Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luminex Corporation and related companies with MarketBeat.com's FREE daily email newsletter.